Ebrahimi Amends Stratasys Ltd. 13D Filing

TL;DR

Ebrahimi updated his Stratasys stake filing on 4/4/24, watch this space.

AI Summary

Farhad Fred Ebrahimi, through a filing on April 4, 2024, has amended his Schedule 13D for Stratasys Ltd. The filing indicates a change in the beneficial ownership of Stratasys Ltd. common stock. Ebrahimi's filing on April 1, 2024, was the event requiring this amendment.

Why It Matters

This amendment to a Schedule 13D filing signals a potential shift in significant shareholder influence or strategy regarding Stratasys Ltd., which could impact its stock price and corporate direction.

Risk Assessment

Risk Level: medium — Amendments to 13D filings often indicate changes in a significant shareholder's intentions, which can lead to increased volatility or strategic shifts for the company.

Key Players & Entities

• Stratasys Ltd. (company) — Subject Company
• Farhad Fred Ebrahimi (person) — Filing Person
• Brad Nelson (person) — Authorized to Receive Notices
• April 4, 2024 (date) — Filing Date
• April 1, 2024 (date) — Date of Event Requiring Filing

FAQ

Key Financial Figures

• $0.01 — statement relates to the common stock, $0.01 par value per share, of Stratasys Ltd.
• $1,240,133 — deration . The Reporting Persons paid $1,240,133 from personal funds to acquire the Comm
• $14.90 — 2024 Purchase of Common Stock 100 $14.90 3/06/2024 Purchase of Common Stock
• $11.64 — 2024 Sale of Common Stock 120,666 $11.64 3/26/2024 Purchase of Common Stock
• $18.16 — 24 Purchase of Common Stock 7,900 $18.16 4/01/2024 Sale of Common Stock 10
• $11.54 — 2024 Sale of Common Stock 100,000 $11.54 All of these transactions were effect
• $15.00 — 1/17/2025 Obligation to buy 200 $15.00 1/17/2025 Obligation to buy 410,8
• $17.50 — 17/2025 Obligation to buy 410,800 $17.50 - 6 - ITEM 7. Material to Be Filed

Filing Documents

• stratasys_ltd.4-3-24_13d.htm (SC 13D/A) — 134KB
• 0000950170-24-041782.txt ( ) — 136KB

Security and Issuer

ITEM 1. Security and Issuer . This statement relates to the common stock, $0.01 par value per share, of Stratasys Ltd. (the Common Stock), a corporation organized under the laws of Israel, with its principal executive offices at 1 Holtzman Street, Science Park, P.O. Box 2496, Rehovot, Israel 7670401.

Identity and Background

ITEM 2. Identity and Background . (a) This statement is being filed by Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi (the Reporting Persons). (b) 191 University Blvd, Suite 246, Denver, Colorado 80206. (c) Farhad Fred Ebrahimi is a private investor, and Mary Wilkie Ebrahimi is not employed. (d) Neither of the Reporting Persons has, during the last five years, been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors). (e) Neither of the Reporting Persons has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding become (or remain) subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities law, or finding any violation with respect to such laws. (f) United States.

Source and Amount of Funds or Other Consideration

ITEM 3. Source and Amount of Funds or Other Consideration . The Reporting Persons paid $1,240,133 from personal funds to acquire the Common Stock.

Purpose of Transaction

ITEM 4. Purpose of Transaction . The Reporting Persons have sold Common Stock in the open market and reduced their holdings to below 5%. The Reporting Persons may make additional sales or purchases of Common Stock or other securities of the Issuer, either in the open market or in private transactions, depending on their evaluation of the Issuer’s business, prospects and financial condition, the market for the Common Stock or other securities, other opportunities available to them, general economic conditions, money and stock market conditions, and other future developments. - 4 - Except as set forth in this document, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer’s business or corporate structure; (g) Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Sectio

INTEREST IN SECURITIES OF THE ISSUER

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER . (a) Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi jointly hold 3,410,795 shares of the Issuer’s Common Stock. Based on the number of shares reported as outstanding in the Issuer’s 6-K, Exhibit 99.1, filed with the Securities Exchange Commission on March 7, 2024, this represents 4.90% of the outstanding Common Stock of the Issuer. (b) Number of shares as to which Farhad Fred Ebrahimi and Mary Wilkie Ebrahimi have: (i) sole power to vote or to direct the vote: 0 shares - 5 - (ii) shared power to vote or to direct the vote: 3,410,795 shares (iii) sole power to dispose or to direct the disposition of: 0 shares (iv) shared power to vote or to direct the vote: 3,410,795 shares (c) The following transactions have been effected by the Reporting Persons in the last 60 days or since their last 13D: Date of Transaction Type of Transaction Quantity Weighted Average Price per Share (in US Dollars) 2/21/2024 Purchase of Common Stock 100 $14.90 3/06/2024 Purchase of Common Stock 73,500 $14.90 3/20/2024 Sale of Common Stock 120,666 $11.64 3/26/2024 Purchase of Common Stock 7,900 $18.16 4/01/2024 Sale of Common Stock 100,000 $11.54 All of these transactions were effected by the Reporting Persons through Fidelity Investments’ online brokerage. (d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of the shares beneficially owned by any of the Reporting Persons. (e) Not applicable

Contracts, Arrangements, Understandings or RelationSHips with Respect to Securities of the Issuer

ITEM 6. Contracts, Arrangements, Understandings or RelationSHips with Respect to Securities of the Issuer . The following PUT options are outstanding that may be exercised by the purchasers. The obligations to buy are subject to conditions which have not occurred and are beyond the Reporting Persons’ control. Expiration Date Type of Transaction Quantity Strike Price 1/17/2025 Obligation to buy 200 $15.00 1/17/2025 Obligation to buy 410,800 $17.50 - 6 -

Material to Be Filed as Exhibits

ITEM 7. Material to Be Filed as Exhibits . Exhibit A - Power of Attorney Exhibit B - Power of Attorney Exhibit C - Agreement regarding filing of joint Schedule 13D. - 7 - SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 3, 2024 By: * Name: Farhad Fred Ebrahimi By: ** Name: Mary Wilkie Ebrahimi *By /s/ Brad Nelson Brad Nelson as Attorney-in-Fact **By: /s/ Brad Nelson Brad Nelson as Attorney-in-Fact *This Schedule 13D/A was executed by Brad Nelson pursuant to a Power of Attorney filed herewith as Exhibit A. **This Schedule 13D/A was executed by Brad Nelson pursuant to a Power of Attorney filed herewith as Exhibit B. - 8 - EXHIBIT INDEX Exhibit A - Power of Attorney Exhibit B - Power of Attorney Exhibit C - Agreement regarding filing of joint Schedule 13D Exhibit A - POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Brad Nelson his true and lawful attorney-in-fact and agent, for him and in his name, place and stead, in any and all capacities (including, but not limited to, as a general partner of any partnership, a member or manager of any limited liability company, a trustee of any trust, or an officer or director of any corporation or other entity), with full power of substitution, to: (i) sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed pursuant to Section 13 or 16 of the Securities Exchange Act of 1934, as amended, and any and all regulations promulgated thereunder, (ii) sign any notice on Form 144 (including any amendments thereto) pursuant to Rule 144 of the Securities Act of 1933, as amended, (iii) file the same (including any amendments thereto), with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exch

View Full Filing

View this SC 13D/A filing on SEC EDGAR